3D Ex vivo tissue platforms to investigate the early phases of influenza a virus- and SARS-CoV-2-induced respiratory diseases

References

• Sungnak W, Huang N, Bécavin C, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26:681–687.
   PubMed Web of Science ®Google Scholar
• Pizzorno A, Padey B, Julien T. Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia. Cell Rep Med. 2020;1:100059.
   PubMedGoogle Scholar
• Banerjee A, Nasir JA, Budylowski P, et al. Isolation, sequence, infectivity, and replication kinetics of severe acute respiratory syndrome coronavirus 2. Emerg Infect Dis. 2020;26:2054–2063.
   PubMed Web of Science ®Google Scholar
• Ou X, Liu Y, Lei X, et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun. 2020;11:1620.
   PubMed Web of Science ®Google Scholar
• Chu H, Chan JF, Yuen TT, et al. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study. Lancet Microbe. 2020;1:e14–e23.
   PubMedGoogle Scholar
• Huang J, Hume AJ, Abo KM, et al. SARS-CoV-2 infection of pluripotent stem cell-derived human lung alveolar type 2 cells elicits a rapid epithelial-intrinsic inflammatory response. Cell Stem Cell. 2020;27:962–973.e967.
   PubMed Web of Science ®Google Scholar
• Bojkova D, Klann K, Koch B, et al. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature. 2020;583:469–472.
   PubMed Web of Science ®Google Scholar
• Sheahan TP, Sims AC, Zhou S, et al. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sci Transl Med. 2020;12:541.
   Web of Science ®Google Scholar
• Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020;5:562–569.
   PubMed Web of Science ®Google Scholar
• Pujhari S, Rasgon JL. Mice with humanized-lungs and immune system - an idealized model for COVID-19 and other respiratory illness. Virulence. 2020;11:486–488.
   PubMed Web of Science ®Google Scholar
• Martina BE, Haagmans BL, Kuiken T, et al. Virology: SARS virus infection of cats and ferrets. Nature. 2003;425:915.
   PubMed Web of Science ®Google Scholar
• Chan JF, Yuan S, Zhang AJ, et al. Surgical mask partition reduces the risk of noncontact transmission in a golden Syrian hamster model for coronavirus disease 2019 (COVID-19). Clin Infect Dis. 2020;71:2139–2149.
   PubMed Web of Science ®Google Scholar
• Muñoz-Fontela C, Dowling WE, Funnell SGP, et al. Animal models for COVID-19. Nature. 2020;586:509–515.
   PubMed Web of Science ®Google Scholar
• Grivel JC, Margolis L. Use of human tissue explants to study human infectious agents. Nat Protoc. 2009;4:256–269.
   PubMed Web of Science ®Google Scholar
• Matos ADR, Wunderlich K, Schloer S, et al. Antiviral potential of human IFN-α subtypes against influenza A H3N2 infection in human lung explants reveals subtype-specific activities. Emerg Microbes Infect. 2019;8:1763–1776.
   PubMed Web of Science ®Google Scholar
• Chu H, Hu B, Huang X, et al. Host and viral determinants for efficient SARS-CoV-2 infection of the human lung. Nat Commun. 2021;12:134.
   PubMed Web of Science ®Google Scholar
• Chan MC, Chan RW, Chan LL, et al. Tropism and innate host responses of a novel avian influenza A H7N9 virus: an analysis of ex-vivo and in-vitro cultures of the human respiratory tract. Lancet Respir Med. 2013;1:534–542.
   PubMed Web of Science ®Google Scholar
• Montagutelli XP, Prot M, Levillayer L, et al. Variants with the N501Y mutation extend SARS-CoV-2 host range to mice, with contact transmission. bioRXiv. 2021.
   Google Scholar
• Schloer S, Brunotte L, Mecate-Zambrano A, et al. Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro. Br J Pharmacol. 2021;178:2339–2350.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego. Calif.) 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Sarkar CP, Bierkamper GG, Cenedella RJ. Studies on the mechanisms of the epileptiform activity induced by U186661. I gross alteration of the lipids of synaptosomes and myelin. Epilepsia. 1982;23:243–255.
   PubMed Web of Science ®Google Scholar
• Cenedella RJ, Bierkamper GG. Mechanism of cataract production by 3-beta(2-diethylaminoethoxy) androst-5-en-17-one hydrochloride, U18666A: an inhibitor of cholesterol biosynthesis. Exp Eye Res. 1979;28:673–688.
   PubMed Web of Science ®Google Scholar
• Hall TJ. Cytotoxicity of vacuolar H(+)-ATPase inhibitors to UMR-106 rat osteoblasts: an effect on iron uptake into cells? Cell Biol Int. 1994;18:189–193.
   PubMed Web of Science ®Google Scholar
• Ohkuma S, Shimizu S, Noto M, et al. Inhibition of cell growth by bafilomycin A1, a selective inhibitor of vacuolar H(+)-ATPase. In Vitro Cell Dev Biol Anim. 1993;29a:862–866.
   PubMed Web of Science ®Google Scholar
• Schloer S, Goretzko J, Rescher U. Repurposing antifungals for host-directed antiviral therapy? Pharmaceuticals. 2022;15:212.
   Web of Science ®Google Scholar
• Fred SM, Kuivanen S, Ugurlu H, et al. Antidepressant and antipsychotic drugs reduce viral infection by SARS-CoV-2 and fluoxetine shows antiviral activity against the novel variants in vitro. Front Pharmacol. 2021;12:755600.
   PubMed Web of Science ®Google Scholar
• Kornhuber J, Tripal P, Reichel M, et al. Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications. Cell Physiol Biochem. 2010;26:9–20.
   PubMed Web of Science ®Google Scholar
• Wang S, Wu J, Wang F, et al. Expression pattern analysis of antiviral genes and inflammatory cytokines in PEDV-infected porcine intestinal epithelial cells. Front Vet Sci. 2020;7:75.
   PubMed Web of Science ®Google Scholar
• Knight AC, Montgomery SA, Fletcher CA, et al. Mouse models for the study of SARS-CoV-2 infection. Comp Med. 2021;71:383–397.
   PubMed Web of Science ®Google Scholar
• Zimniak M, Kirschner L, Hilpert H, et al. The serotonin reuptake inhibitor fluoxetine inhibits SARS-CoV-2 in human lung tissue. Sci Rep. 2021;11:5890.
   PubMed Web of Science ®Google Scholar
• Mulay A, Konda B, Garcia G, Jr., et al. SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery. Cell Rep. 2021;35:109055.
   PubMed Web of Science ®Google Scholar
• Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nat Rev Immunol. 2014;14:36–49.
   PubMed Web of Science ®Google Scholar
• Ciancanelli MJ, Abel L, Zhang SY, et al. Host genetics of severe influenza: from mouse Mx1 to human IRF7. Curr Opin Immunol. 2016;38:109–120.
   PubMed Web of Science ®Google Scholar
• Rehwinkel J, Gack MU. RIG-I-like receptors: their regulation and roles in RNA sensing. Nat Rev Immunol. 2020;20:537–551.
   PubMed Web of Science ®Google Scholar
• Rösler B, Herold S. Lung epithelial GM-CSF improves host defense function and epithelial repair in influenza virus pneumonia-a new therapeutic strategy? Mol Cell Pediatr. 2016;3:29.
   PubMedGoogle Scholar
• Lu F, Liang Q, Abi-Mosleh L, et al. Identification of NPC1 as the target of U18666A, an inhibitor of lysosomal cholesterol export and Ebola infection. ELife. 2015;4:e12177.
   PubMed Web of Science ®Google Scholar
• Lange Y, Ye J, Rigney M, et al. Dynamics of lysosomal cholesterol in niemann-pick type C and normal human fibroblasts. J Lipid Res. 2002;43:198–204.
   PubMed Web of Science ®Google Scholar
• Mercer J, Schelhaas M, Helenius A. Virus entry by endocytosis. Annu Rev Biochem. 2010;79:803–833.
   PubMed Web of Science ®Google Scholar
• Wang R, Wang J, Hassan A, et al. Molecular basis of V-ATPase inhibition by bafilomycin A1. Nat Commun. 2021;12:1782.
   PubMed Web of Science ®Google Scholar
• Bonsergent E, Grisard E, Buchrieser J, et al. Quantitative characterization of extracellular vesicle uptake and content delivery within mammalian cells. Nat Commun. 2021;12:1864.
   PubMed Web of Science ®Google Scholar
• Tang Y, Leao IC, Coleman EM, et al. Deficiency of niemann-pick type C-1 protein impairs release of human immunodeficiency virus type 1 and results in Gag accumulation in late endosomal/lysosomal compartments. J Virol. 2009;83:7982–7995.
   PubMed Web of Science ®Google Scholar
• Elgner F, Ren H, Medvedev R, et al. The intracellular cholesterol transport inhibitor U18666A inhibits the exosome-dependent release of mature hepatitis C virus. J Virol. 2016;90:11181–11196.
   PubMed Web of Science ®Google Scholar
• Rein T. Harnessing autophagy to fight SARS-CoV-2: an update in view of recent drug development efforts. J Cell Biochem. 2022;123:155–160.
   PubMed Web of Science ®Google Scholar
• Kummer S, Lander A, Goretzko J, et al. Pharmacologically induced endolysosomal cholesterol imbalance through clinically licensed drugs itraconazole and fluoxetine impairs Ebola virus infection in vitro. Emerg Microbes Infect. 2022;11:195–207.
   PubMed Web of Science ®Google Scholar
• Schloer S, Goretzko J, Kühnl A, et al. The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo. Emerg Microbes Infect. 2019;8:80–93.
   PubMed Web of Science ®Google Scholar
• Schloer S, Brunotte L, Goretzko J, et al. Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine. Emerg Microbes Infect. 2020;9:2245–2255.
   PubMed Web of Science ®Google Scholar
• Brunotte L, Zheng S, Mecate-Zambrano A, et al. Combination therapy with fluoxetine and the nucleoside analog GS-441524 exerts synergistic antiviral effects against different SARS-CoV-2 variants in vitro. Pharmaceutics. 2021;13:1400.
   PubMed Web of Science ®Google Scholar